Literature DB >> 1375599

Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.

L Katznelson1, J M Alexander, H A Bikkal, J L Jameson, D W Hsu, A Klibanski.   

Abstract

Clinically nonfunctioning pituitary adenomas represent approximately 25% of all pituitary tumors. Recent studies using a number of in vitro techniques show that the majority of such tumors produce gonadotropins. Hypersecretion of uncombined gonadotropin subunits by these tumors has also been identified raising the possibility that gonadotropin biosynthetic alterations may occur in neoplastic pituitary tissue. To determine whether underlying intracellular biosynthetic alterations lead to imbalanced secretion of the gonadotropin subunits by such tumors, we investigated 1) steady state gonadotropin-subunit messenger ribonucleic acid (mRNA) levels in tumor tissue from 49 patients with clinically nonfunctioning adenomas, 2) secretion of gonadotropins in dispersed pituitary tumor cultures, and 3) serum concentrations of gonadotropins and free subunits. Northern blots of RNA extracted from surgically obtained pituitary tumor tissue were hybridized with complementary DNA probes for FSH beta, LH beta, and alpha-subunit, and quantitative analysis was done to compare alpha- and beta-subunit biosynthesis in individual tumors. Of these tumors, 47 contained sufficient RNA for Northern analysis and 77% of these tumors contained one or more of the gonadotropin-subunit mRNAs. Steady state alpha-subunit mRNA was detected in 57% of tumors, FSH beta mRNA in 49%, and LH beta in 1 (2%). We found FSH beta mRNA in excess of alpha-subunit mRNA in one-third of tumors, including 9 tumors where alpha-subunit mRNA was undetectable. In cultured cells, FSH beta was secreted in excess of alpha-subunit in 41% of tumors. For those tumors in which both mRNA and culture data were available, FSH beta mRNA and secreted subunit levels were in excess of alpha-subunit in 64% of tumors. We conclude that clinically nonfunctioning pituitary adenomas frequently synthesize excess FSH beta subunit relative to alpha-subunit. This finding is in contrast to previous data in normal pituitary or placental tissue where alpha-subunit is present in excess of beta-subunits at both the mRNA and protein levels. The free-beta-subunit hypersecretion identified in pituitary adenomas may be due to biosynthetic abnormalities intrinsic to neoplastic gonadotrophs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375599     DOI: 10.1210/jcem.74.6.1375599

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Urinary beta-luteinizing hormone and beta-follicle stimulating hormone immunoenzymometric assays for population research.

Authors:  Eleanor Brindle; Rebecca C Miller; Jane B Shofer; Nancy A Klein; Michael R Soules; Kathleen A O'Connor
Journal:  Clin Biochem       Date:  2006-09-01       Impact factor: 3.281

Review 2.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 3.  Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.

Authors:  Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2010-03-06       Impact factor: 4.102

4.  Immunodetection of glycoprotein hormone subunits in nonfunctioning and glycoprotein hormone-secreting pituitary adenomas.

Authors:  K Saccomanno; M Bassetti; A Lania; M Losa; G Faglia; A Spada
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

Review 5.  Endocrine inactive and gonadotroph adenomas: diagnosis and management.

Authors:  M Losa; P Mortini; R Barzaghi; A Franzin; M Giovanelli
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

6.  Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro.

Authors:  J M Alexander; A Klibanski
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Ectopic secretion of LH by an endocrine pancreatic tumor.

Authors:  E Brignardello; R Manti; M Papotti; E Allìa; D Campra; G Isolato; M C Cassinis; G Fronda; G Boccuzzi
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

Review 8.  Updating the Landscape for Functioning Gonadotroph Tumors.

Authors:  Georgia Ntali; Cristina Capatina
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

9.  Abnormally Elevated Follicle-Stimulating Hormone (FSH) Level in an Infertile Woman.

Authors:  Aurore Catteau; Kalyane Bach-Ngohou; Justine Blin; Paul Barrière; Thomas Fréour; Damien Masson
Journal:  Case Rep Endocrinol       Date:  2019-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.